In Appeal To Federal Circuit, Makers Of Colitis Drug Dispute Claim Construction

(March 6, 2020, 1:29 PM EST) -- WASHINGTON, D.C. — A Delaware federal judge took a “shortcut” when construing various disputed claim terms in a patent used in the ulcerative colitis drug “Uceris” and other systems for delivering...
To view the full article, register now.